List of pharmacopoeia

Pharmacopoeia is an official publication describing drugs, chemicals, and medicinal preparations as well as containing directions of compound identification. The word ‘Pharmacopoeia’ is widely used and common spelling but ‘Pharmacopeia’ used only in USP.

1. List of Pharmacopoeia
By Tushar chavan
M Pharmacy 2019-2020
K.Y.D.S.C.T.College of Pharmacy, Sakegaon
NMU, Jalgaon [MH]
Email: [email protected]
Updated Aug 25, 2019

Pharmacopoeia means ″drug -making″ or ″to make a drug″. This word
derives from the ancient Greek (pharmakopoiia), from (pharmako) ″drug″,
followed by the verb-stem (poi) ″make″ and finally the abstract noun ending
(-ia).
Pharmacopoeia is an official publication describing drugs, chemicals, and
medicinal preparations as well as containing directions of compound
identification. The word ‘Pharmacopoeia’ is widely used and common spelling
but ‘Pharmacopeia’ used only in USP.
 Pharmacopoeia: British spelling
 Pharmacopeia: American spelling
Remember that, a detailed written study of a single specialized subject is
called monograph. A monograph contains but not limi ted to the name of the
ingredient, the definition, preparation, storage, packaging, and labeling
requirements; and the specifications. The specification contains a series of
tests, procedures for the tests, and acceptance criteria. A list of
pharmacopoeia are given below:

A. United States Pharmacopeia

2. Its INN system symbol is USP. The USP is issued in a combined with the
National Formulary as the USP-NF. The USP is an official compendium for
drugs marketed in the U.S. and annually published by the United States
Pharmacopeial Convention. To avoid probable charges of adulteration an d
misbranding, a drug product in the U.S.A market must conform to the
standards in USP–NF.
Monographs for drug substances, compounded preparations, and dosage
forms are presented in the USP. Monographs for dietary supplements and
ingredients present in a distinct section of the USP. Monographs for
Excipients are in the NF.
On 15th December 1820, the first edition of United States Pharmacopeia was
published in both English and Latin. It was published annually since 2002.
First National Formulary of the U.S. appeared in 1888. In 1992, the
electronic version of USP-NF on floppy disks was introduced. USP has
laboratories in India, Brazil, China, and the United States.
B. British Pharmacopoeia
Its INN system symbol is BP. Since 1864, BP has been supplying official
standards for medicines. It was consist of two sections.
 Part I: – Materia Medica
 Part II: – Preparation & compounds
In 1953, the eighth edition of BP was published. In this edition titles of drugs
and preparations were in English in lieu of Latin and metric system. Annually
BP has been published. In BP 2007 monographs has been presented for
material specifically used in the preparation of Traditional Chinese medicines.
The term “Gastro-resistant” has been substituted with “Enteric coated” and
the term “Prolonged release” has been substituted the term “Slow” in the
number of monographs. The Pharmacopoeial Secretariat working in
collaboration with the British Pharmacopoeia Commission (BPC), the British
Pharmacopoeia Laboratory, and its Expert Advisory Groups (EAG) and
Advisory Panels has been publishing the British Pharmacopoeia.
C. European Pharmacopoeia
Its INN system symbol is Ph. Eur. It is Europe’s legal and scientific
benchmark for pharmacopoeial standards. It helps to deliver high-quality
medicines in Europe and beyond. It is a published collection of monographs
that describe active and inactive ingredients, methods of analysis for
medicines, descriptions of reagents, animal, human or herbal origin,
homoeopathic stocks and homoeopathic preparations, antibiotics, vaccines as
well as dosage forms and containers. It also contains texts on biologicals,
blood and plasma derivatives, and radiopharmaceutical preparations. In
1969, the first edition of the Ph. Eur. was published which consisted of 120
texts.

3.  Book Version: Available in English or French.
 Online Version: Cumulative, tablet and smartphone friendly. Bilingual
(English and French).
 Downloadable version: Cumulative and bilingual (English and French).
D. International Pharmacopoeia
The International Pharmacopoeia has been published by the World Health
Organization (WHO). Its INN system symbol is Ph. Int. In 1951, the first
volume of International Pharmacopoeia was published. The International
Pharmacopoeia (Ph. Int.) constitutes a collection of recommended
procedures for analysis and specifications for the determination of
pharmaceutical substances and dosage forms that are intended to serve as
source material for reference or adaptation by any WHO Member State
wishing to establish pharmaceutical requirements. The Eighth Edition of The
International Pharmacopoeia was published in 2018.
E. Japanese Pharmacopoeia
Its INN system symbol is JP. The JP (日本薬局方 ) is the official pharmacopoeia
of Japan. Pharmaceuticals and Medical Devices Agency under the authority of
the Ministry of Health, Labour and Welfare have been published JP. The first
edition was published on 25 June 1886, with revisions being issued from time
to time. The current revision is number 17, issued electronically in English
language on 7 March 2016. On 25 June 1886, JP was first published and
implemented in July 1887 and issued electronically in English language on 7
March 2016 and JP has been revised periodically.
F. Indian Pharmacopoeia
Its INN system symbol is JP. The IP is the official pharmacopoeia of India.
Indian Pharmacopoeia Commission (IPC) has been publi shed IP under the
authority of the Ministry of Health & Family Welfare, Government of India.
For manufacturing, selling medicine in India market IPC sets standards.
IP-2018 contains 4 Volumes incorporating 220 new monographs (Chemical
Monographs (170), Herbal Monographs (15), Veterinary monographs (14),
Blood and Blood-related products (10), Biotechnology-Derived Therapeutic
Products (06), Radiopharmaceutical monographs (03), Vaccines and
Immunosera for Human use monographs (02)) as well as 366 revised
monographs and 7 omissions.
G. Chinese Pharmacopoeia
Its INN system symbol is ChP. The Pharmacopoeia Commission under the
authority of the Ministry of Health of the People’s Republic of China has been
published the Pharmacopoeia of the People’s Republic of China (PPRC) or
ChP. ChP is an official compendium of drugs which covering traditional
Chinese and western medicines, which includes information but not limited to

4. description, the standards of purity, test, precaution, storage, strength and
dosage for each drug. Also, it is recognized as the official Chinese
pharmacopoeia by the WHO.
 Monographs of Volume I deal with Chinese material medica and pared slice,
Chinese traditional patent medicines, vegetable oil/fat, and its extract, single
ingredient of Chinese crude drug preparations etc.
 Monographs of Volume II contains antibiotics, chemical drugs, biochemical
preparations, Radiopharmaceuticals as well as excipients for pharmaceutical
use.
 Monographs of Volume III deal with biological products.
H. Others Pharmacopoeia
1. French Pharmacopoeia
2. Brazilian Pharmacopoeia
3. Czech Pharmacopoeia
4. Mexican Pharmacopoeia
5. Royal Spanish Pharmacopoeia